A closure system includes a non-child resistant cap configured to screw on and off a container in a non-child resistant mode. The system further includes a child resistant element configured to be able to be assembled with the non-child resistant cap to convert the non-child resistant cap to a child resistant cap permitting a push-down-and-turn action to remove the child resistant cap from a container. A child proof element is separate from the child resistant element is configured to be able to be assembled with the non-child resistant cap to convert the non-child resistant cap to a child proof cap requiring a key to remove the child proof cap from a container.

According to one embodiment, a tablet printing apparatus includes: a conveyor belt that includes a suction hole connected to a suction chamber, and conveys a tablet while sucking the tablet to the suction hole; an ink jet print head that has a nozzle surface where a nozzle is formed, and is located above the conveyor belt such that the nozzle surface faces the conveyor belt, and performs printing on the tablet conveyed by the conveyor belt; and a control plate that is located on the upstream side of the print head in the conveying direction of the tablet between the conveyor belt and the height position of the nozzle surface of the print head, and controls an airflow generated between the conveyor belt and the print head.

A tray (100) for accommodating a coiled medical device, such as a catheter assembly (700), includes a first compartment (101), a second compartment (102), and a third compartment (103). The catheter assembly (700) and devices associated with a catheterization procedure, such as syringes (701,702) containing sterile water and lubricating jelly and a specimen container (703) can be disposed within the tray. Printed instructions (1001) can be included with the tray (100). One or more layers of wrap material (2200) can be folded about the tray (100) to enclose the tray (100) and other items, such as an additional layer of wrap material (2701), packaged liquid hand sanitizer (2401), and packaged gloves (2402). When a health care services provider (3101) unfolds the wrap material, the same can be used to create a sterile field beneath a patient (3201).

A method for packaging a medication including receiving a prescription for a patient including a name of the medication for the patient and a name of the patient, wherein the patient is one of a plurality of family members. The method further comprises receiving a family member listing from the patient identifying one or more other ones of the plurality of family members, assigning a color to the patient that differs from any of one or more colors assigned to any of the other ones of the plurality of family members identified in the family member listing, and packaging the medication for delivery to the patient including securing a color-coded member to the container for the medication. The color-coded member is the color assigned to the patient.

The invention relates to methods for decreasing adverse events associated with pirfenidone (5-methyl-1-phenyl-2-(1H)-pyridone) therapy. The invention discloses an optimized dose escalation scheme that results in the patient having increased tolerance to adverse events associated with the administration of pirfenidone. The invention also discloses a starter pack that may be used in conjunction with the dose escalation scheme.

A pharmaceutical pack and the method for making the same are provided. The pharmaceutical pack includes a blister layer and a lidding sheet disposed over the blister layer. The blister layer defines at least one opening. The lidding sheet includes a first layer and optionally a second layer. The first layer includes at least one hologram, and is disposed on the second layer, which is a plastic film. The blister layer and the lidding sheet define at least one cavity so as to hold at least one pharmaceutical dosage form therein.

A device can include an alert mechanism and a detection mechanism. The alert mechanism can activate an alert for a user to take a medication from a target medication receptacle. The detection mechanism can detect a tag associated with a medication receptacle. Actions may be performed based on a correlation between the detected tag and the target medication receptacle, such as deactivating the alert based at least in part on detecting the tag associated with the target medication receptacle.

An indicator for identifying a condition to be treated by a medication is disclosed. The indicator is supported on a cap that closes a medicine container. The indicator includes a base coupled to the cap and an upper component that extends upwardly away from the base and includes a first side and a second side. The first side and second side of the upper component includes a usage indicia, which includes a visual representation of a condition to be treated by the medication. The usage indicia is supported by the upper component such that the usage indicia is visible to the user. The upper component presents a surface area larger than the cap to display the visual representation. The first and second sides are planar for easier viewing of the visual representation while the container is stored.

A bottle with time indication device for indicating a selected time includes a bottle containing a perishable liquid. A nipple is removably positioned upon the bottle and provides an access for a mouth of a user to suck the perishable liquid out from the bottle. A collar removably secures the nipple to the bottle and a time indicator is coupled to the collar and displays a selected time of day, thus the selected time of day corresponds to using the perishable liquid within the bottle.

A pharmaceutical container houses a substance for treating an individual having a medical condition. A disposable pouch has a primary layer and a secondary layer and defining a pouch chamber. A first pharmaceutical substance is within the pouch chamber for treating the medical condition. A second pharmaceutical substance is within the pouch chamber for treating the medical condition. The first pharmaceutical substance and the second pharmaceutical substance define a fixed-dose combination drug for ingestion by the individual for treating the medical condition.